Oritavancin 68225-0051-01
- Manufacturer
- Patheon Italia S.p.a
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 1, 2014
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oritavancin | 400 mg/1 |
Selected Package
68225-0051-01Selected7344 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER (68225-051-01)